FBP1 and p27kip1 expression after sciatic nerve injury: Implications for schwann cells proliferation and differentiation

Journal of Cellular Biochemistry

Volumn 115, Issue 1, 2014, Pages 130-140

  Yao, Li ^a,b   Cao, Jianhua ^a   Sun, Huiqing ^a   Guo, Aisong ^b   Li, Aihong ^b   Ben, Zhiyun ^b   Zhang, Haiyan ^b   Wang, Xinxiu ^b   Ding, Zongmei ^b   Yang, Xiaojing ^b   Huang, Xianting ^b   Ji, Yuhong ^b   Zhou, Zhengming ^a  

^a NANTONG UNIVERSITY   (China)

^b NANTONG MEDICAL COLLEGE   (China)

Author keywords

CIATIC NERVE INJURY; DIFFERENTIATION; FBP1; p27; PROLIFERATION; SCHWANN CELLS

Indexed keywords

CYCLIC AMP; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FAR UPSTREAM ELEMENT BINDING PROTEIN 1; KI 67 ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 6; PROTEIN P27; SINGLE STRANDED DNA BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MOTILITY; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSFECTION; IN VITRO STUDY; MALE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE CRUSH; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; SCHWANN CELL; SCIATIC NERVE INJURY;

CIATIC NERVE INJURY; DIFFERENTIATION; FBP1; P27; PROLIFERATION; SCHWANN CELLS;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYCLIC AMP; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; DNA-BINDING PROTEINS; KI-67 ANTIGEN; MALE; NERVE CRUSH; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SCHWANN CELLS; SCIATIC NERVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887969906     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24640     Document Type: Article

References (57)

1. Akassoglou K, Yu WM, Akpinar P, Strickland S,. 2002. Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron 33: 861-875.
2. Arroyo EJ, Bermingham JR, Jr., Rosenfeld MG, Scherer SS,. 1998. Promyelinating Schwann cells express Tst-1/SCIP/Oct- 6. J Neurosci 18: 7891-7902.
3. Atanassov BS, Dent SY,. 2011. USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1. EMBO Rep 12: 924-930.
4. Avigan MI, Strober B, Levens D,. 1990. A far upstream element stimulates c-myc expression in undifferentiated leukemia cells. J Biol Chem 265: 18538-18545.
5. Baldassarre G, Boccia A, Bruni P, Sandomenico C, Barone MV, Pepe S, Angrisano T, Belletti B, Motti ML, Fusco A, Viglietto G,. 2000. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth Differ 11: 517-526.
6. Bryja V, Pachernik J, Vondracek J, Soucek K, Cajanek L, Horvath V, Holubcova Z, Dvorak P, Hampl A,. 2008. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin. Cell Prolif 41: 875-893.
7. Cao G, Kuriyama S, Du P, Sakamoto T, Kong X, Masui K, Qi Z,. 1997. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer. Gastroenterology 112: 501-510.
8. Carruthers S, Mason J, Papalopulu N,. 2003. Depletion of the cell-cycle inhibitor p27(Xic1) impairs neuronal differentiation and increases the number of ElrC(+) progenitor cells in Xenopus tropicalis. Mech Dev 120: 607-616.
9. Chen L, Qin J, Cheng C, Niu S, Liu Y, Shi S, Liu H, Shen A,. 2008a. Spatiotemporal expression of SSeCKS in injured rat sciatic nerve. Anat Rec (Hoboken) 291: 527-537.
10. Chen M, Cheng C, Yan M, Niu S, Gao S, Shi S, Liu H, Qin Y, Shen A,. 2008b. Involvement of CAPON and nitric oxide synthases in rat muscle regeneration after peripheral nerve injury. J Mol Neurosci 34: 89-100.
11. Chien HL, Liao CL, Lin YL,. 2011. FUSE binding protein 1 interacts with untranslated regions of Japanese encephalitis virus RNA and negatively regulates viral replication. J Virol 85: 4698-4706.
12. Chung HJ, Liu J, Dundr M, Nie Z, Sanford S, Levens D,. 2006. FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol 26: 6584-6597.
13. Davis-Smyth T, Duncan RC, Zheng T, Michelotti G, Levens D,. 1996. The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators. J Biol Chem 271: 31679-31687.
14. Deng X, Wei H, Lou D, Sun B, Chen H, Zhang Y, Wang Y,. 2012. Changes in CLIP3 expression after sciatic nerve injury in adult rats. J Mol Histol 43: 669-679.
15. Doetsch F, Verdugo JM, Caille I, Alvarez-Buylla A, Chao MV, Casaccia-Bonnefil P,. 2002. Lack of the cell-cycle inhibitor p27Kip1 results in selective increase of transit-amplifying cells for adult neurogenesis. J Neurosci 22: 2255-2264.
16. Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M, Levens D,. 1994. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev 8: 465-480.
17. Duncan R, Collins I, Tomonaga T, Zhang T, Levens D,. 1996. A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strand-binding protein FBP. Mol Cell Biol 16: 2274-2282.
18. Durand B, Gao FB, Raff M,. 1997. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16: 306-317.
19. Eser F, Aktekin LA, Bodur H, Atan C,. 2009. Etiological factors of traumatic peripheral nerve injuries. Neurol India 57: 434-437.
20. Fawcett JW, Keynes RJ,. 1990. Peripheral nerve regeneration. Annu Rev Neurosci 13: 43-60.
21. Fu SY, Gordon T,. 1997. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14: 67-116.
22. Han IS, Seo TB, Kim KH, Yoon JH, Yoon SJ, Namgung U,. 2007. Cdc2-mediated Schwann cell migration during peripheral nerve regeneration. J Cell Sci 120: 246-255.
23. He L, Liu J, Collins I, Sanford S, O'Connell B, Benham CJ, Levens D,. 2000. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J 19: 1034-1044.
24. Hokfelt T, Zhang X, Wiesenfeld-Hallin Z,. 1994. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 17: 22-30.
25. Hunter T, Pines J,. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582.
26. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J,. 1993. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-beta. Science 260: 536-539.
27. Kohoutek J, Dvorak P, Hampl A,. 2004. Temporal distribution of CDK4, CDK6, D-type cyclins, and p27 in developing mouse oocytes. Biol Reprod 70: 139-145.
28. Kozar K, Sicinski P,. 2005. Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 4: 388-391.
29. Liu J, Kouzine F, Nie Z, Chung HJ, Elisha-Feil Z, Weber A, Zhao K, Levens D,. 2006. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J 25: 2119-2130.
30. Lou D, Sun B, Wei H, Deng X, Chen H, Xu D, Li G, Xu H, Wang Y,. 2012. Spatiotemporal expression of testicular protein kinase 1 after rat sciatic nerve injury. J Mol Neurosci 47: 180-191.
31. Ma J, Chen M, Xia SK, Shu W, Guo Y, Wang YH, Xu Y, Bai XM, Zhang L, Zhang H, Zhang M, Wang YP, Leng J,. 2013. Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression. Int J Oncol 42: 1093-1104.
32. Miyazawa K, Himi T, Garcia V, Yamagishi H, Sato S, Ishizaki Y,. 2000. A role for p27/Kip1 in the control of cerebellar granule cell precursor proliferation. J Neurosci 20: 5756-5763.
33. Morgan DO,. 1995. Principles of CDK regulation. Nature 374: 131-134.
34. Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P,. 2006. Pathophysiology of disk-related low back pain and sciatica. II. Evidence supporting treatment with TNF-alpha antagonists. Joint Bone Spine 73: 270-277.
35. Ohira M, Ohdan H, Mitsuta H, Ishiyama K, Tanaka Y, Igarashi Y, Asahara T,. 2006. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Transplantation 82: 1712-1719.
36. Olanich ME, Moss BL, Piwnica-Worms D, Townsend RR, Weber JD,. 2011. Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene 30: 77-86.
37. Pollheimer J, Knofler M,. 2005. Signalling pathways regulating the invasive differentiation of human trophoblasts: A review. Placenta 26 (Suppl. A): S21-S30.
38. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J,. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
39. Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu ML, Joos S, Devens F, Lichter P, Rieker RJ, Trojan J, Chung HJ, Levens DL, Zornig M,. 2009. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology 50: 1121-1129.
40. Robinson LR,. 2000. Traumatic injury to peripheral nerves. Muscle Nerve 23: 863-873.
41. Schafers M, Geis C, Brors D, Yaksh TL, Sommer C,. 2002. Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci 22: 536-545.
42. Sgambato A, Cittadini A, Faraglia B, Weinstein IB,. 2000. Multiple functions of p27(Kip1) and its alterations in tumor cells: A review. J Cell Physiol 183: 18-27.
43. Sheikh MS, Huang Y,. 2004. Death receptors as targets of cancer therapeutics. Curr Cancer Drug Targets 4: 97-104.
44. Sherr CJ,. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-555.
45. Sherr CJ, Roberts JM,. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
46. Shy ME, Shi Y, Wrabetz L, Kamholz J, Scherer SS,. 1996. Axon-Schwann cell interactions regulate the expression of c-jun in Schwann cells. J Neurosci Res 43: 511-525.
47. Sturm I, Stephan C, Gillissen B, Siebert R, Janz M, Radetzki S, Jung K, Loening S, Dorken B, Daniel PT,. 2006. Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ 13: 619-627.
48. Toyoshima H, Hunter T,. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
49. Verdu E, Navarro X,. 1995. Degeneration and regeneration of the peripheral nervous system with aging. Rev Neurol 23: 648-655.
50. Vindigni A, Ochem A, Triolo G, Falaschi A,. 2001. Identification of human DNA helicase V with the far upstream element-binding protein. Nucleic Acids Res 29: 1061-1067.
51. Wagner R, Myers RR,. 1996. Schwann cells produce tumor necrosis factor alpha: Expression in injured and non-injured nerves. Neuroscience 73: 625-629.
52. Wang Y, Liu Y, Chen Y, Shi S, Qin J, Xiao F, Zhou D, Lu M, Lu Q, Shen A,. 2009. Peripheral nerve injury induces down-regulation of Foxo3a and p27kip1 in rat dorsal root ganglia. Neurochem Res 34: 891-898.
53. Wang Y, Tang X, Yu B, Gu Y, Yuan Y, Yao D, Ding F, Gu X,. 2012. Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nerves. PLoS ONE 7: e43436.
54. Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Ito M, Takase K, Moriyama M, Nakano T, Suzuki A,. 2000. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 32: 482-490.
55. Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV, Koff A,. 2001. p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep 2: 27-34.
56. Zheng Y, Miskimins WK,. 2011. Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int J Biochem Cell Biol 43: 1641-1648.
57. Zindy F, Cunningham JJ, Sherr CJ, Jogal S, Smeyne RJ, Roussel MF,. 1999. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc Natl Acad Sci USA 96: 13462-13467.